+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term survival after pharmacosensitivity-directed adjuvant four-drug chemotherapy in stage II node-positive and stage IIIA breast cancer patients



Long-term survival after pharmacosensitivity-directed adjuvant four-drug chemotherapy in stage II node-positive and stage IIIA breast cancer patients



International Journal of Oncology 7(Suppl. ): 960




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 032194656

Download citation: RISBibTeXText


Related references

Stage-to-stage comparison of neoadjuvant chemotherapy versus adjuvant chemotherapy in pathological lymph node positive breast cancer patients. Japanese Journal of Clinical Oncology 42(11): 995-1001, 2013

Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial. Journal of Clinical Oncology 23(12): 2686-2693, 2005

Taxane-based adjuvant chemotherapy in node positive, early stage Turkish breast cancer patients. Central European Journal of Medicine 4(4): 454-458, 2009

Long-term follow-up of a phase II trial studying a weekly doxorubicin-based multiple drug adjuvant therapy for stage II node-positive carcinoma of the breast. Breast Cancer Research & Treatment 72(3): 233-243, 2002

Long term follow-up for a weekly doxorubicin multiple drug adjuvant therapy for stage II node-positive carcinoma of the breast Phase II trial of the Piedmont Oncology Association. Breast Cancer Research & Treatment 37(Suppl. ): 78, 1996

Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer. Cancer Research 47(2): 624-630, 1987

Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen. Cancer Research 48(4): 1026-1029, 1988

Endocrinology of adjuvant chemotherapy and long term tamoxifen therapy in premenopausal and postmenopausal node positive breast cancer patients. Breast Cancer Research & Treatment 6(2): 183, 1985

Is adjuvant chemotherapy omissible in women with T1-2 stage, node-positive, luminal A type breast cancer?. Journal of ChemoTherapy 27(5): 290-296, 2016

Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients. Breast 17(6): 646-653, 2008

Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy. Bmc Cancer 16: 460, 2017

Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B. Gynecologic Oncology 107(1): 154-156, 2007

Preoperative chemotherapy for operable breast cancer is associated with better compliance with adjuvant therapy in matched stage II and IIIA patients. Oncologist 16(6): 742-751, 2011

CMF versus CNF as adjuvant chemotherapy for stage II lymph-node positive breast cancer A phase III randomized multicenter study. American Journal of Clinical Oncology 24(4): 323-327, 2001

CMF versus CNF as adjuvant chemotherapy for stage II lymph-node positive breast cancer Results by demographic and clinical subgroups. American Journal of Clinical Oncology 25(5): 520-522, 2002